×
The Effects of Risperidone on the Five Dimensions of Schizophrenia Derived by Factor Analysis: Combined Results of the North American Trials PDF
$ 40.00
The Effects of Risperidone on the Five Dimensions of Schizophrenia Derived by Factor Analysis: Combined Results of the North American Trials PDF quantity
$ 40.00
×
Transcranial Magnetic Stimulation in the Acute Treatment of Major Depressive Disorder: Clinical Response in an Open-Label Extension Trial PDF
$ 40.00
Transcranial Magnetic Stimulation in the Acute Treatment of Major Depressive Disorder: Clinical Response in an Open-Label Extension Trial PDF quantity
$ 40.00
×
Insomnia and Objectively Measured Sleep Disturbances Predict Treatment Outcome in Depressed Patients Treated With Psychotherapy or Psychotherapy-Pharmacotherapy Combinations PDF
$ 40.00
Insomnia and Objectively Measured Sleep Disturbances Predict Treatment Outcome in Depressed Patients Treated With Psychotherapy or Psychotherapy-Pharmacotherapy Combinations PDF quantity
$ 40.00
×
The Efficacy and Safety of the Melatonin Agonist beta-Methyl-6-Chloromelatonin in Primary Insomnia: A Randomized, Placebo-Controlled, Crossover Clinical Trial PDF
$ 40.00
The Efficacy and Safety of the Melatonin Agonist beta-Methyl-6-Chloromelatonin in Primary Insomnia: A Randomized, Placebo-Controlled, Crossover Clinical Trial PDF quantity
$ 40.00
×
Rapid Development of Lorazepam Tolerance Within 48 Hours in an Adult With Intellectual Disability Who Presented With Stuporous Catatonia and Refused Electroconvulsive Therapy PDF
$ 40.00
Rapid Development of Lorazepam Tolerance Within 48 Hours in an Adult With Intellectual Disability Who Presented With Stuporous Catatonia and Refused Electroconvulsive Therapy PDF quantity
$ 40.00
×
The Abuse of Prescription Medications in Borderline Personality Disorder: A Gender Comparison PDF
$ 40.00
The Abuse of Prescription Medications in Borderline Personality Disorder: A Gender Comparison PDF quantity
$ 40.00
×
Efficacy of Controlled-Release Paroxetine in the Treatment of Late-Life Depression PDF
$ 40.00
Efficacy of Controlled-Release Paroxetine in the Treatment of Late-Life Depression PDF quantity
$ 40.00
×
Prevalence and Correlates of Benzodiazepine Use, Misuse, and Use Disorders Among Adults in the United States PDF
$ 40.00
Prevalence and Correlates of Benzodiazepine Use, Misuse, and Use Disorders Among Adults in the United States PDF quantity
$ 40.00
×
Prevalence and 3-Year Psychiatric and Mental Health Outcomes of Primary and Secondary Mood Disorders PDF
$ 40.00
Prevalence and 3-Year Psychiatric and Mental Health Outcomes of Primary and Secondary Mood Disorders PDF quantity
$ 40.00
×
Sertraline Versus Paroxetine in the Treatment of Panic Disorder: An Acute, Double-Blind Noninferiority Comparison PDF
$ 40.00
Sertraline Versus Paroxetine in the Treatment of Panic Disorder: An Acute, Double-Blind Noninferiority Comparison PDF quantity
$ 40.00
×
Baseline Characteristics and Early Response at Week 1 Predict Treatment Outcome in Adolescents With Bipolar Manic or Mixed Episode Treated With Olanzapine: Results From a 3-Week, Randomized, Placebo-Controlled Trial PDF
$ 40.00
Baseline Characteristics and Early Response at Week 1 Predict Treatment Outcome in Adolescents With Bipolar Manic or Mixed Episode Treated With Olanzapine: Results From a 3-Week, Randomized, Placebo-Controlled Trial PDF quantity
$ 40.00
×
Insurance Coverage and Health Outcomes in Young Adults With Mental Illness Following the Affordable Care Act Dependent Coverage Expansion PDF
$ 40.00
Insurance Coverage and Health Outcomes in Young Adults With Mental Illness Following the Affordable Care Act Dependent Coverage Expansion PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
